Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial
采用重组干扰素α单药治疗及联合醋酸甲羟孕酮治疗晚期肾细胞癌:一项随机多中心试验
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/BF00390492
Porzsolt, F; Messerer, D; Hautmann, R; Gottwald, A; Sparwasser, H; Stockamp, K; Aulitzky, W; Moormann, J G; Schumacher, K; Rasche, H